GSP Crop Science IPO GMP: Today is the last day to bid on the IPO of GSP Crop Science, which manufactures pesticides and plant growth-enhancing chemicals. Investors can invest in its Rs 400 crore IPO until March 18. New shares will be issued under this issue, and shares will also be sold through an offer for sale window. The company aims to raise Rs 400 crore through the public issue.
As of the final day of subscription, the issue was subscribed 1.05 times, receiving 94,25,676 bids against 89,47,367 shares on offer.
GSP Crop Science’s Rs 400 crore IPO is available in a price band of Rs 304-320 and in lots of 46 shares. One lot comprises 46 shares. Retail investors wishing to invest in this IPO will need to invest a minimum of Rs 14,720.
GSP Crop Science: Important Dates
GSP Crop Science IPO Subscription
- Qualified Institutional Buyers (QIBs): 1.28 times
- Non-Institutional Investors (NIIs): 2.55 times
- Retail Individual Investors (RIIs): 0.28 times
The demand has been largely driven by institutional investors, while retail participation remains relatively subdued.
GSP Crop Science: Anchor Investors
Before the IPO opened, the company raised Rs 120 crore from several large investors. These included two funds, Shine Star Build Cap Private Limited and Kraft Emerging Markets Fund. These investors were offered 37.50 lakh shares at a price of Rs 320 per share.
The grey market premium (GMP) indicates a moderate listing outlook. Currently, the GMP stands at Rs 0, suggesting an estimated listing price of around Rs 320 per share.
How many shares will be issued?
In this IPO, the company will issue new shares worth Rs 240 crore. Additionally, existing investors (promoters) will sell 5 million shares. This will result in the promoters reducing their stake.
The registrar for this IPO is MUFG Intime India. After allotment, you can check whether you received shares by visiting its website or the BSE website.
Of the Rs 240 crore fresh issue, Rs 170 crore will be used for repayment or prepayment of outstanding borrowings (total debt of Rs 478.8 crore as of December 2025, including Rs 282.7 crore fund-based), while the remaining will be allocated toward general corporate purposes such as working capital, product development, registrations, marketing, and other growth initiatives; additionally, Rs 160 crore raised through the OFS will go to selling shareholders, Vilasben Vrajmohan Shah, Bhavesh Vrajmohan Shah, and Kappa Trust, and will not be used by the company.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money related decisions.)
